Physician profile
Robert Matthew Smith
NPI 1720216831
$3,378.68
in general payments reported to CMS, 2019-2025
25 companies · $395 in 2025
The $395 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,767 · 2020: $70.98 · 2021: $299 · 2022: $248 · 2023: $130 · 2024: $469 · 2025: $395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $994.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $993.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $1,389.79 | 2019 | |
| Janssen Biotech, INC. | $419.31 | 2019-2024 | Erleada, Akeega |
| Astellas Pharma US INC | $283.83 | 2019-2023 | Myrbetriq |
| Urogen Pharma, INC. | $260.99 | 2024-2025 | |
| Pfizer INC. | $156.80 | 2019-2025 | |
| 180 Medical, INC. | $127.52 | 2019-2025 | Gentlecath Glide, Gentlecath |
| Axonics, INC. | $124.82 | 2022-2024 | Axonics, Bulkamid |
| Endo USA, INC. | $103.17 | 2024-2025 | Xiaflex |
| Abbvie INC. | $93.00 | 2023-2025 | Botox |
| Sumitomo Pharma America, INC. | $79.20 | 2023-2025 | Gemtesa |
| Endo Pharmaceuticals INC. | $43.75 | 2021-2024 | Xiaflex |
| Vertex Pharmaceuticals Incorporated | $39.23 | 2025 | |
| Procept Biorobotics Corporation | $39.12 | 2024 | Aquabeam System |
| Bayer Healthcare Pharmaceuticals INC. | $35.23 | 2021 | |
| Sun Pharmaceutical Industries INC. | $34.70 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $19.06 | 2019-2025 | Axonics |
| Medtronic USA, INC. | $17.64 | 2019 | |
| Antares Pharma, INC. | $16.38 | 2024 | Xyosted |
| Cook Medical LLC | $14.78 | 2022 | |
| Urovant Sciences INC | $14.41 | 2022 | |
| Medtronic, INC. | $14.13 | 2021 | |
| Rochester Medical Corporation | $13.72 | 2021 | |
| Ambu INC. | $13.43 | 2021 | |
| Teleflex LLC | $13.07 | 2024 | |
| Janssen Pharmaceuticals, INC | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.